Insulin-like growth factor 1 receptor (IGF-1R) inhibitor: another arrow in the quiver - Will it hit the moving target?
- PMID: 21936711
- DOI: 10.1517/13543784.2011.619978
Insulin-like growth factor 1 receptor (IGF-1R) inhibitor: another arrow in the quiver - Will it hit the moving target?
Abstract
Insulin-like growth factor 1 receptor (IGF-1R) inhibitors have anti-tumor activity in various cancers. The development of IGF-1R inhibitors is a multi-dimensional and complex issue, involving many different drugs, and affecting several different points along the pathway. Matching patients with these agents based on molecular profiling/signatures will be essential for the proper development of this type of targeted agent.
Comment on
-
Targeting the insulin-like growth factor signaling pathway: figitumumab and other novel anticancer strategies.Expert Opin Investig Drugs. 2011 Sep;20(9):1293-304. doi: 10.1517/13543784.2011.602630. Epub 2011 Jul 22. Expert Opin Investig Drugs. 2011. PMID: 21777167 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources